Loading provider…
Loading provider…
Surgery Physician in Fullerton, CA
NPI: 1467409250Primary Practice Location
PROVIDENCE ST. JUDE MEDICAL CENTER
101 E Valencia Mesa Dr, Fullerton, CA
Primary Employer
Providence Medical Foundation
psjhmedgroups.org
HQ Phone
Get MD Theodoros's Phone Numberphone_androidMobile
Get MD Theodoros's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2005 - 2027

American Board of Surgery
Surgery

American Board of Thoracic Surgery
Thoracic Surgery
University of Athens
Medical School
Until 1953
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 49 | 52 |
| 2 | 99203New patient outpatient visit, total time 30-44 minutes | 36 | 36 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 29 | 31 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 29 | 60 |
| 5 | 47563Removal of gallbladder with X-ray study of bile ducts using endoscope | 26 | 26 |
Authors: Wilpert, Jochen, Fischer, Karl-Georg, Pisarski, Przemyslaw, Wiech, Thorsten, Daskalakis, Michael, Ziegler, Anna, Neumann-Haefelin, Elke, Drognitz, Oliver, Emmerich, Florian, Walz, Gerd, Geyer, Marcel
Journal: Nephrol Dial Transplant
Publication Date: 2010-04-28
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment
Authors: Michael Daskalakis, TuDung T. Nguyen, Carvell T. Nguyen, Per Guldberg, Gabriele Köhler, Pierre W. Wijermans, Peter A. Jones, Michael Lübbert
Publication Date: 2002-10
Epigenetische Therapie bei Myelodysplastischen Syndromen (MDS). Therapie mit DNA-Methyltransferase-Inhibitoren
Authors: Michael Daskalakis, Nadja Blagitko-Dorfs, Björn Hackanson, Michael Lübbert